Clearmind Medicine Inc. Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets
Clearmind Medicine Inc. (CMND) reported Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets of $3.26 thousand for the 12-month period ending 2025-10-31, per its 20-F filed 2026-01-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets · last filed 2026-03-12
- Clearmind Medicine Inc. expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets for the quarter ending 2025-10-31 was $0.00, a 100.00% decline year-over-year.
- Clearmind Medicine Inc. expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets for the quarter ending 2025-07-31 was $0.00, a 100.00% decline year-over-year.
- Clearmind Medicine Inc. expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets for the quarter ending 2025-04-30 was $0.00, a 100.00% decline year-over-year.
- Clearmind Medicine Inc. expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets for the quarter ending 2025-01-31 was $3.26K, a 0.00% change year-over-year.
| Period end | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 3 month | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 3 month as first filed | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 6 month | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 9 month | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month |
|---|---|---|---|---|---|
| 2025-10-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $0.00 derived: sum of 2 quarters · filed 2026-01-20 | $0.00 derived: sum of 3 quarters · filed 2026-01-20 | $3.26K 20-F · filed 2026-01-20 | |
| 2025-07-31 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $0.00 derived: sum of 2 quarters · filed 2025-09-11 | $3.26K 6-K · filed 2025-09-11 | $10.48K derived: sum of 4 quarters · filed 2026-01-20 | |
| 2025-04-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | $3.26K 6-K · filed 2025-06-12 | $10.48K derived: sum of 3 quarters · filed 2026-01-20 | $25.36K derived: sum of 4 quarters · filed 2026-01-20 | |
| 2025-01-31 | $3.26K 6-K · filed 2025-03-13 | $10.48K derived: sum of 2 quarters · filed 2026-01-20 | $25.36K derived: sum of 3 quarters · filed 2026-01-20 | $48.65K derived: sum of 4 quarters · filed 2026-01-20 | |
| 2024-10-31 | $7.21K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $22.09K derived: sum of 2 quarters · filed 2026-01-20 | $45.38K derived: sum of 3 quarters · filed 2026-01-20 | $79.00K 20-F · filed 2026-01-20 | |
| 2024-07-31 | $14.88K 6-K · filed 2025-09-11 | $38.17K derived: sum of 2 quarters · filed 2025-09-11 | $71.79K 6-K · filed 2025-09-11 | ||
| 2024-04-30 | $23.29K 6-K · filed 2025-06-12 | $56.87K 6-K · filed 2025-06-12 | |||
| 2024-01-31 | $3.26K 6-K · filed 2026-03-12 | $33.58K 6-K · filed 2025-03-13 | |||
| 2023-10-31 | $221.63K 20-F · filed 2025-01-22 |